Wall Street Zen upgraded shares of Wellgistics Health (NASDAQ:MEDS – Free Report) from a strong sell rating to a hold rating in a report published on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Wellgistics Health in a report on Monday, September 21st. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat, Wellgistics Health has a consensus rating of “Sell”.
Check Out Our Latest Analysis on MEDS
Wellgistics Health Stock Performance
NASDAQ:MEDS opened at $1.34 on Friday. The stock has a market cap of $7.66 million, a P/E ratio of -0.07 and a beta of -3.14. The company has a current ratio of 0.14, a quick ratio of 0.10 and a debt-to-equity ratio of 8.53. The stock’s 50-day moving average is $2.47 and its 200-day moving average is $4.68. Wellgistics Health has a 1-year low of $0.49 and a 1-year high of $33.12.
About Wellgistics Health
Wellgistics Health is a U.S.-focused healthcare services and technology company centered on pharmaceutical distribution. It supplies prescription medicines, including branded and generic drugs, to pharmacies and other healthcare providers. The company also offers technology and services intended to support pharmacy purchasing, inventory management and connections among drug manufacturers, distributors and pharmacies. Its business is particularly oriented toward serving independent pharmacies. Wellgistics Health combines pharmaceutical wholesale distribution with technology-enabled pharmacy services.
Further Reading
- Five stocks we like better than Wellgistics Health
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.
